Frankfurt - Delayed Quote EUR
Transgene SA (TGNA.F)
0.5980
+0.0040
+(0.67%)
At close: April 25 at 8:04:30 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 6.7M | 6.7M |
| Low Estimate | -- | -- | 6.7M | 6.7M |
| High Estimate | -- | -- | 6.7M | 6.7M |
| Year Ago Sales | -- | -- | 6.35M | 6.7M |
| Sales Growth (year/est) | -- | -- | 5.46% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TGNA.F | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
BV3.BE Bavarian Nordic A/S
20.88
+1.66%
ALVAL.PA Valbiotis SA
1.0160
+2.00%
BVNKF Bavarian Nordic A/S
23.07
0.00%
IPH.PA Innate Pharma S.A.
1.7580
-0.11%
IPHA Innate Pharma S.A.
1.9800
0.00%
VLA.PA Valneva SE
3.1540
+0.25%
CADL Candel Therapeutics, Inc.
4.9800
-0.40%
EDIT Editas Medicine, Inc.
1.5400
-4.35%